Background: Homocysteine is a metabolite of methionine with atherogenic properties via endothelial dysfunction. Endothelial dysfunction is one of main pathophysiologic mechanisms of coronary vasospasm. We examined the relationship between the risk of patients with coronary vasospasm and serum total homocysteine (tHcy), folate, vitamin B 12 , and plasma vitamin B 6 . Methods: Fasting serum tHcy, folate, vitamin B 12 , and plasma vitamin B 6 concentrations were measured in 25 patients (15 men, age 52.8±10.1) with coronary vasospasm and compared with 22 healthy control subjects matching in age and sex (10 men, age 52.7±9.2). Serum tHcy concentration was higher in the vasospasm group than in the control group (14.8±5.3 vs 10.1±2.5 μmol/L, p<0.001).
Introduction
Homocysteine is a sulfur containing amino acid derived from the metabolism of methionine and has athergogenic and thrombogenic properties. It is regarded as a risk factor for artherosclerotic coronary artery disease. [1] [2] [3] [4] Homocysteine is readily oxidized, leading to the formation of superoxide and hydrogen peroxide. This oxidant stress may play an important role in endothelial damage, which occurs easily before the development of overt structural changes in coronary artery disease. 5)6) Several animal and clinical studies have shown homocysteine to reduce the bioavailabilty of endothelium-derived relaxing factors (EDRF) or endothelium derived nitric oxide (NO).
7)
Increased blood homocysteine levels are associated with impaired flow-mediated vasodilation at the brachial artery. [8] [9] [10] Flow-mediated vasodialtion of the brachial artery is a good indicator of endothelial function and was reported to correlate with coronary circulation.
11)
Vasospasm of the coronary artery can cause various features of ischemic heart disease syndrome, including variant angina, myocardial infarction, and even sudden cardiac death.
12) The deficiency of endothelial nitric oxide (NO) activity plays an important role in the pathogenesis of coronary vasospasm. 13 ) Therefore, we hypothesized that mild to moderate elevations in the serum total homocysteine concentrations (tHcy) are associated with decreased nitric oxide bioavailability and coronary vasospasm. Accordingly, we compared the level of fasting serum tHcy and related substrates to the level of homocysteine in patients with coronary vasospasm and in control subjects.
Methods

Study patients
This study included 25 patients who were diagnosed with vasospastic angina between January 1996 and December 1997 at Hallym University hospital. If typical angina symptoms, focal reversible coronary vasospasms, and transient ECG changes of myocardial ischemia occurred during coronary angiogram with ergonovine or during the acetylcholine provocation test, a diagnosis of vasospastic angina was made. All angina patients, due to coronary vasospasms, had angiographically documented reversible coronary vasospasms associated with ischemic ST segment changes, with chest pain or chest discomfort, and had no visible fixed significant stenosis on coronary angiogram. With the 22 control subjects, detailed medical histories were taken and physical examinations were performed. The patients and the control subjects were matched by age and sex. The exclusion criteria contained the following: impaired renal function (serum creatinine over 2.0 mg/dL), anemia, hepatic disease, current use of vitamin compositions, malignancy, and herb medication.
Measurement
Serum and plasma were obtained after overnight fasting and were promptly spun, separated, and frozen at -20℃. High-performance liquid chromatography with fluorescent detection methods was used for the rapid determination of tHcy concentration. 14) Serum folate and vitamin B 12 levels were measured using radioassay kits. Plasma vitamin B 6 levels were measured by radioenzyme assay. Other laboratory tests included measurements of fasting serum total cholesterol, HDL-cholesterol, triglyceride, lipoprotein (a), and fibrinogen. LDL-cholesterol levels were calculated by the Friedewald equation. Body mass index was calculated by dividing body weight (Kg) by the square of height (m).
Statistical analysis
Continuous variables were expressed as mean±stan-dard deviation, and the Mann-Whitney U test was used to compare means between the two groups. Fisher's exact test was used to compare categorical variables between the groups. Variables that showed significance were included in multivariated logistic regression for evaluating intervariable correlations. P values less than 0.05 were considered statistically significant.
Results
Basic clinical characteristics
The clinical characteristics of the study populations are shown in Table 1 . There was no significant difference in age, sex, total cholesterol, triglyceride, HDLcholesterol, LDL-cholesterol, and BMI between the two groups. The frequency of hypertension and diabetes were also similar between the two groups. The history of cigarette smoking, which was higher in the vasospasm group, was the only difference (p<0.05).
Serum total homocysteine, folate, vitamin B12, vitamin B6 concentrations
Serum concentrations of tHcy were higher in patients with coronary vasospasm than in the control subjects (14.8±5.3 versus 10.1±2.5 μmol/L, p<0.001, Figure 1 ).
Compared with the control group, the vasospasm group showed lower serum folate concentrations (10.2±4.5 
Discussion
In the present cross sectional and case-control study, patients with coronary vasospasm showed higher serum total homocysteine concentration than the control patients. This suggests that increased serum homocysteine is associated with coronary vasospasm.
Coronary vasospasm can cause variable clinical features of myocardial ischemia. Despite its clinical significance, the factors responsible for coronary artery hypersensitivity to vasoconstricting stimuli are still unknown.
From the results of several studies, cigarette smoking is the most accepted characteristic clinical risk factor for coronary vasospasm, but its association with other conventional risk factors is weak. 15)16) Similarly, only cigarette smoking showed a significant difference between the two groups in this study. Serum total homocyteine is also independently associated with coronary vasospasm. Among the mechanisms of pathogenesis of coronary vasospasm, impaired endothelial function is regarded as one of the main pathophysiologic mechanisms. Endothelial dysfunction manifests an impaired bioavailability of endothelium derived relaxing factor (EDRF). EDRF is a diffusible vasodilator from vascular endothelium and causes vascular smooth muscle relaxation. Moreover, reports have suggested nitric oxide (NO) to be the substance of EDRF. 17) EDRF can be released by platelet products, thrombin, hormones, neurotransmitters, local autacoids, and by change of local blood flow.
18) The response to variations in shear stress significantly affects the change in diameter of large arteries in response to increased blood flow, which is called flow-mediated vasodilation. 19) In canine coronary arteries, acute endothelial injury by a balloon-tipped catheter causes enhanced contraction in response to serotonin. 20) Furthermore, the combination of balloon removal of endothelium with hypercholesterolemic diet caused atherosclerotic lesions and selective vasospasms where the endothelium was removed with myocardial ischemia in the porcine model. 21) Some data suggest that coronary vasospasm is associated with endothelial dysfunction in human. Reports have also suggested genetic enzyme defects in endothelial NO synthesis to be a risk factor for coronary vasospasm. 22) Moreover, the endothelium dependent flow-mediated dilation in the brachial artery was impaired in patients with vasospastic angina. [23] [24] [25] Mild to moderate elevation of serum homocysteine is now regarded as a risk factor for thrombotic and atherosclerotic vascular disease. Homocysteine readily oxidizes, leading to the formation of superoxide and hydrogen peroxide, and this oxidant stress may play an important role in endothelial dysfunction, which is a major pathophysiologic mechanism for artherosclerosis and coronary vasospasm. There have been several reports indicating that hyperhomocysteinemia is related with vascular endothelial dysfunction, which easily occurs before the development of overt structural vascular disease. Harker et al. reported that adding homocysteine to a culture medium caused endothelial injury. Furthermore, they reported that intravenous infusion of homocysteine in baboons caused patch endothelial detatchment. 5) No data has shown the association of homocysteine with coronary vasospasm. The above studies, however, demonstrated that increased homocysteine concentration is associated with impaired endothelium-dependent vasodilation, employed at the brachial or femoral arteries to estimate flow mediated endothelium-dependent vasodilation. And the flow-mediated endothelium-dependent were lower in the vasospasm group than in the control group. Although the activity of MTHFR was not evaluated, the results of this study suggest that relatively low levels of these vitamins are associated with increased homocyteine levels in patients with coronary vasospasm.
In conclusion, we demonstrated that serum total homocyteine concentration increased in patients with coronary vasospasm. Further studies are needed to explain the causal relationship by which another therapeutic modality for coronary vasospasm can be expected.
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